Trial Profile
Capecitabine Metronomic Chemotherapy Combined With Aromatase Inhibitors in Postmenopausal Hormone-receptor-positive Breast Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Anastrozole; Exemestane; Letrozole
- Indications Advanced breast cancer; Ductal carcinoma
- Focus Adverse reactions
- 02 Mar 2017 New trial record